Literature DB >> 8139046

The Bel1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids.

C W Lee1, J Chang, K J Lee, Y C Sung.   

Abstract

The Bel1 transactivator is essential for the replication of human foamy virus (HFV). To define the functional domains of HFV Bel1, we generated random missense mutations throughout the entire coding sequence of Bel1. Functional analyses of 24 missense mutations have revealed the presence of at least two functional domains in Bel1. One domain corresponds to a basic amino acid-rich motif which acts as a bipartite nuclear targeting sequence. A second, central domain corresponds to a presumed effector region which, when mutated, leads to dominant-negative mutants and/or lacks transactivating ability. In addition, deletion analyses and domain-swapping experiments further showed that Bel1 protein contains a strong carboxy-terminal activation domain. The activating region is also capable of functioning as a transcription-activating domain in yeast cells, although it does not bear any significant sequence homology to the well-characterized acidic activation domain which is known to function only in yeast and mammalian cells. We also demonstrated that the regions of Bel1 from residues 1 to 76 and from residues 153 to 225 repressed transcriptional activation exerted by the Bel1 activation domain. In contrast, the region from residues 82 to 150 appears to overcome an inhibitory effect. These results indicate that Bel1 contains one positive and two negative regulatory domains that modulate a distinct activation domain of Bel1. These regulatory domains of Bel1 cannot affect the function of the VP16 activation domain, suggesting that these domains specifically regulate the activation domain of Bel1. Furthermore, in vivo competition experiments showed that the positive regulatory domain acts in trans. Thus, our results demonstrate that Bel1-mediated transactivation appears to undergo a complex regulatory pathway which provides a novel mode of regulation for a transcriptional activation domain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139046      PMCID: PMC236748     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.

Authors:  F Sanger; A R Coulson
Journal:  J Mol Biol       Date:  1975-05-25       Impact factor: 5.469

Review 2.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

3.  Deletion analysis of GAL4 defines two transcriptional activating segments.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

Review 4.  Transcriptional selectivity of viral genes in mammalian cells.

Authors:  S McKnight; R Tjian
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

Authors:  E Giniger; M Ptashne
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Immunoglobulin gene transcription is activated by downstream sequence elements.

Authors:  C Queen; D Baltimore
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

8.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

Authors:  I A Hope; K Struhl
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

9.  Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus.

Authors:  H P Bogerd; R A Fridell; W S Blair; B R Cullen
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

View more
  9 in total

1.  Intra- and intercellular trafficking of the foamy virus auxiliary bet protein.

Authors:  Charles-Henri Lecellier; Wim Vermeulen; Françoise Bachelerie; Marie-Lou Giron; Ali Saïb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Identification of two independent transcriptional activation domains in the Autographa californica multicapsid nuclear polyhedrosis virus IE1 protein.

Authors:  J M Slack; G W Blissard
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Deletion analysis of both the long terminal repeat and the internal promoters of the human foamy virus.

Authors:  P Yang; M Zemba; M Aboud; R M Flügel; M Löchelt
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses.

Authors:  I Winkler; J Bodem; L Haas; M Zemba; H Delius; R Flower; R M Flügel; M Löchelt
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter.

Authors:  J X Zou; P A Luciw
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

6.  Human foamy virus Bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains.

Authors:  J Chang; K J Lee; K L Jang; E K Lee; G H Baek; Y C Sung
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7.

Authors:  Jihui Duan; Zhiqin Tang; Hong Mu; Guojun Zhang
Journal:  Int J Mol Med       Date:  2016-06-09       Impact factor: 4.101

8.  SGK1, a Serine/Threonine Kinase, Inhibits Prototype Foamy Virus Replication.

Authors:  Junshi Zhang; Chunhua Han; Zhenjie Xiong; Manman Qiu; Xiaopeng Tuo; Chenchen Wang; Wentao Qiao; Juan Tan
Journal:  Microbiol Spectr       Date:  2022-04-19

Review 9.  Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission.

Authors:  Timo Kehl; Juan Tan; Magdalena Materniak
Journal:  Viruses       Date:  2013-09-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.